Ravi Orugunty

Dr. Orugunty has two doctorate degrees from the University of Florida in Medicinal Chemistry and Organic Chemistry. He is experienced with bioanalytical and analytical chemistry. He has extensive product development experience with his tenure at Cerilliant (EMD MilliporeSigma). Further, Ravi has extensive experience in bioanalytical method development and validation gained from his tenure with Worldwide Clinical Trials Inc. Dr. Orugunty's efforts will facilitate the development of novel therapeutic products in Sano's pipeline.